Table 1 General characteristics of study population
Characteristics | CIPN Cases (148) | Controls (835) | |||||
|---|---|---|---|---|---|---|---|
Mean age | 57.48 | 57.30 | |||||
Gender male % | 86 (58%) | 493 (59%) | |||||
History of neuropathy | 21 (14.2%) | 30 (3.6%) | |||||
Medication | Medication | ||||||
Bortezomib | Vincristine | Thalidomide | Bortezomib | Vincristine | Thalidomide | ||
Study | HD3 | – | 4 | 6 | – | 53 | 40 |
HD4 | 28 | 15 | – | 116 | 132 | – | |
MM5 | 47 | – | – | 394 | – | – | |
NTP | 27 | 10 | 11 | 34 | 60 | 6 | |
Total | 102 (68.9%) | 29 (19.6%) | 17 (11.5%) | 544 (65.2%) | 245 (29.3%) | 46 (5.5%) | |